A pre-treatment CT-based weighted radiomic approach combined with clinical characteristics to predict durable clinical benefits of immunotherapy in advanced lung cancer

OBJECTIVES: To develop a pre-treatment CT-based predictive model to anticipate inoperable lung cancer patients' progression-free survival (PFS) to immunotherapy. METHODS: This single-center retrospective study developed and cross-validated a radiomic model in 185 patients and tested it in 48 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhenchen, Chen, Minjiang, Hu, Ge, Pan, Zhengsong, Han, Wei, Tan, Weixiong, Zhou, Zhen, Wang, Mengzhao, Mao, Li, Li, Xiuli, Sui, Xin, Song, Lan, Xu, Yan, Song, Wei, Yu, Yizhou, Jin, Zhengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Chest
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748402/
https://www.ncbi.nlm.nih.gov/pubmed/36515714
http://dx.doi.org/10.1007/s00330-022-09337-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748402/
https://www.ncbi.nlm.nih.gov/pubmed/36515714
http://dx.doi.org/10.1007/s00330-022-09337-7

Ejemplares similares